pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 718 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Marketed
    mebendazole
    Emverm (mebendazole)
    Ancylostomiasis (Hookworm Infections)$AMRX Amneal Pharmaceuticals, Inc.
  • Marketed
    mefloquine hydrochloride
    Mefloquine Hydrochloride
    Malaria Barr Laboratories Inc
  • Phase 2
    meningococcal (pentavalent) vaccine
    MenPenta
    Neisseria meningitidis Infections$SNY Sanofi
← prev
page 20 of 24
next →
Pain89
Neurology1
Phase 3
meningococcal [serotype B] vaccine
Bexsero
Neisseria meningitidis Infections
$GSK GSK plc
  • Marketed
    meningococcal [serotype C] vaccine
    Menomune-C
    Neisseria meningitidis Infections Sanofi Pasteur Inc
  • Marketed
    meningococcal [serotypes A, B, C, W-135, Y] vaccine
    Penmenvy
    Neisseria meningitidis Infections GlaxoSmithKline LLC
  • Marketed
    meningococcal [serotypes A, C, W-135, Y] vaccine
    Menveo
    Neisseria meningitidis Infections GlaxoSmithKline LLC
  • Marketed
    meningococcal [serotypes A, C, W-135, Y] vaccine (Menactra)
    Menactra
    Neisseria meningitidis Infections Sanofi Pasteur Inc
  • Phase 2
    meplazumab
    Ketantin
    Malaria Jiangsu Pacific Meinuoke Bio-Pharmarceutical Co Ltd
  • Phase 1
    meropenem + pilabactam
    meropenem [INN] + pilabactam [INN]
    Acinetobacter Infections Antabio SAS
  • Marketed
    miconazole nitrate
    Monistat 7 (miconazole nitrate)
    Vulvovaginal Candidiasis Insight Pharmaceuticals LLC
  • Marketed
    miltefosine
    Impavido (miltefosine [INN])
    Visceral Leishmaniasis (Kala-Azar) Profounda Inc
  • Phase 2
    mosedipimod
    mosedipimod
    Coronavirus Disease 2019 (COVID-19) Associated Acute Resp… Enzychem Lifesciences Corp
  • Phase 2
    moxidectin
    Moxidectin
    Scabies Atticus Medical Pty Ltd
  • Marketed
    mupirocin calcium
    Mupirocin Calcium
    Impetigo Amneal Pharmaceuticals of New York LLC
  • Phase 1
    nafamostat mesylate
    nafamostat mesylate
    Coronavirus Disease 2019 (COVID-19)$ENSC Ensysce Biosciences, Inc.
  • Marketed
    nafcillin sodium
    Nafcillin Sodium
    Bacterial Endocarditis Claris Lifesciences Inc
  • Marketed
    naftifine hydrochloride
    Naftin (naftifine hydrochloride)
    Tinea Corporis Legacy Pharma Solutions
  • Marketed
    nelfinavir mesylate
    Viracept (nelfinavir mesylate)
    Human Immunodeficiency Virus (HIV) Infections (AIDS)$PFE PFIZER INC
  • Marketed
    nevirapine
    Nevirapine
    Human Immunodeficiency Virus (HIV) Infections (AIDS) Camber Pharmaceuticals Inc
  • Marketed
    nifurtimox
    Lampit (nifurtimox [INN])
    Chagas Disease (American Trypanosomiasis) Bayer HealthCare Pharmaceuticals Inc
  • pre_registration
    nirmatrelvir + ritonavir
    Paxlovid (nirmatrelvir + ritonavir)
    Coronavirus Disease 2019 (COVID-19)$PFE PFIZER INC
  • Phase 1
    nitazoxanide
    Alinia (nitazoxanide)
    Acute On Chronic Liver Failure (ACLF) Genfit SA
  • Phase 1
    norovirus [strain GI.1] vaccine
    Norovirus Infections$VXRT Vaxart, Inc.
  • Marketed
    nystatin
    Nystatin (nystatin [INN])
    Chronic Mucocutaneous Candidiasis Actavis Mid Atlantic LLC
  • Marketed
    obiltoxaximab
    Anthim (obiltoxaximab)
    Anthrax Elusys Therapeutics Inc
  • Marketed
    omadacycline tosylate
    Nuzyra (omadacycline tosylate)
    Mycobacterium Infections Paratek Pharmaceuticals Inc
  • Marketed
    oritavancin diphosphate
    Orbactiv (oritavancin diphosphate)
    Skin And Skin Structure Infections (SSSI) Caused By Bacteria A. Menarini Industrie Farmaceutiche Riunite Srl
  • Marketed
    oteseconazole
    Vivjoa (oteseconazole)
    Onychomycosis (Tinea Unguium) Mycovia Pharmaceuticals Inc
  • Marketed
    oxacillin
    Bactocill (oxacillin [INN])
    Staphylococcal Infections Baxter Healthcare Corp